<div id="readability-page-1">02:22 PM EST, 12/09/2025 (MT Newswires) -- Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index down 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.5%.The iShares Biotechnology ETF (IBB) fell 1%.In corporate news, Pfizer ( PFE ) said that it has signed an exclusive global collaboration and licensing deal with YaoPharma, a unit of Shanghai Fosun Pharmaceutical, to develop, make and commercialize YP05002 for chronic weight management. Pfizer ( PFE ) shares were down 0.9%.CVS Health ( CVS ) lifted its full-year outlook on Tuesday amid ongoing efforts to strengthen its core businesses, while the healthcare company said it expects earnings in 2026 to be higher than the previous year. Its shares rose 2.9%.Teleflex (TFX) said Tuesday it agreed to sell its Acute Care, Interventional Urology and OEM units for a combined $2.03 billion in cash. Its shares jumped past 11%. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

Health care stocks declined, with NYSE Health Care Index down 0.4%. Pfizer signed a deal with YaoPharma for weight management drug YP05002, shares down 0.9%. CVS Health raised its full-year outlook, shares up 2.9%. Teleflex sold units for $2.03 billion, shares up 11%.

- Health care stocks experienced a decline, with the NYSE Health Care Index down 0.4% and the State Street Health Care Select Sector SPDR ETF decreasing 0.5%.  
- Pfizer announced a global collaboration with YaoPharma for chronic weight management, resulting in a 0.9% drop in its shares, while CVS Health raised its full-year outlook, leading to a 2.9% increase in its stock.  
- Teleflex agreed to sell several units for $2.03 billion in cash, causing its shares to rise over 11%.

Sector Update: Health Care Stocks Lower in Afternoon Trading